Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in the west of what was then the Kingdom of Prussia, today modern Germany. "What started as a small but innovative dyestuffs ...

King in those last days of his life was speaking to how the environment and the conditions in which people live and work ...

Bayer is pressing ahead with a phase ... with prior ischaemic stroke or high-risk TIA, on top of aspirin and antiplatelet therapy. The drug numerically reduced the risk of clinical ischaemic ...

.Semaglutide: Novo Nordisk Semaglutide is a long-acting oral GLP-1 analogue being developed and investigated by Novo Nordisk. The drug is currently being evaluated under Phase III clinical trial for ...

Partially offsetting this are declines in cardiovascular drug Xarelto ... margins. Bayer’s healthcare segment also includes a consumer healthcare business with leading brands Aspirin and Aleve.

The prevalence of daily low-dose aspirin use fell significantly after the American College of Cardiology and the American ...

Anthos Therapeutics' abelacimab shows lower bleeding risk vs Xarelto in atrial fibrillation trial, with 62% reduction in ...

Bayer pleaded with Missouri lawmakers Thursday to pass legislation critics say would shield the company from lawsuits ...

The Preeclampsia Foundation has found a formula for closing the maternal health equity gap: Mix one part equity-forward ...

Expert Rev Cardiovasc Ther. 2012;10(4):433-439. This article suggests the need to reconsider the benefits of using aspirin in stroke prevention, especially in low-risk patients or patients not ...

Pain Management Market Advancements in non-opioid therapies, AI-integrated solutions, and regenerative <a target=_blank href= ...